Versant Capital Management, Inc Biomarin Pharmaceutical Inc Transaction History

Versant Capital Management, Inc

  • $431 Million
  • Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 85 shares of BMRN stock, worth $5,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Previous 101 15.84%
Holding current value
$5,390
Previous $8,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$69.02 - $93.84 $1,104 - $1,501
-16 Reduced 15.84%
85 $5,000
Q2 2024

Jul 05, 2024
BUY
$74.43 - $92.22 $6,475 - $8,023
87 Added 621.43%
101 $8,000
Q1 2024

Apr 03, 2024
SELL
$83.81 - $99.0 $754 - $891
-9 Reduced 39.13%
14 $1,000
Q4 2023

Jan 08, 2024
BUY
$76.22 - $98.51 $457 - $591
6 Added 35.29%
23 $2,000
Q3 2023

Oct 11, 2023
SELL
$85.07 - $94.48 $765 - $850
-9 Reduced 34.62%
17 $1,000
Q2 2023

Jul 10, 2023
BUY
$86.68 - $100.3 $1,040 - $1,203
12 Added 85.71%
26 $2,000
Q2 2022

Aug 02, 2022
BUY
$71.48 - $86.85 $214 - $260
3 Added 27.27%
14 $1,000
Q3 2021

Oct 29, 2021
SELL
$74.77 - $85.47 $299 - $341
-4 Reduced 26.67%
11 $1,000
Q2 2021

Jul 22, 2021
BUY
$75.51 - $84.79 $302 - $339
4 Added 36.36%
15 $1,000
Q4 2020

Feb 08, 2021
SELL
$72.61 - $90.2 $290 - $360
-4 Reduced 26.67%
11 $0
Q1 2020

Apr 17, 2020
SELL
$71.37 - $96.85 $214 - $290
-3 Reduced 16.67%
15 $1,000
Q4 2019

Jan 28, 2020
SELL
$64.27 - $86.37 $964 - $1,295
-15 Reduced 45.45%
18 $1,000
Q3 2019

Oct 18, 2019
SELL
$67.4 - $85.11 $2,426 - $3,063
-36 Reduced 52.17%
33 $2,000
Q2 2019

Jul 16, 2019
SELL
$80.35 - $93.9 $1,205 - $1,408
-15 Reduced 17.86%
69 $5,000
Q1 2019

Apr 23, 2019
BUY
$84.2 - $98.62 $6,483 - $7,593
77 Added 1100.0%
84 $7,000
Q1 2019

Apr 23, 2019
SELL
$84.2 - $98.62 $6,904 - $8,086
-82 Reduced 92.13%
7 $7,000
Q3 2017

Apr 23, 2018
SELL
$80.6 - $94.95 $241 - $284
-3 Reduced 3.26%
89 $8,000
Q1 2017

Apr 23, 2018
SELL
N/A
-35 Reduced 27.56%
92 $8,000
Q4 2016

Apr 23, 2018
SELL
N/A
-14 Reduced 9.93%
127 $10,000
Q2 2016

Apr 23, 2018
SELL
N/A
-7 Reduced 4.73%
141 $10,000
Q1 2016

Apr 23, 2018
BUY
N/A
18 Added 13.85%
148 $12,000
Q4 2015

Apr 23, 2018
BUY
N/A
130
130 $13,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email